Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion type Assertion NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_head.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion description "[We sought to determine whether administration of a MGMT blocker, O(6)-benzyl guanine (O(6)BG), at an optimal biological dose alone or in combination with gemcitabine inhibits human pancreatic cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion evidence source_evidence_literature NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion SIO_000772 19789303 NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion wasDerivedFrom befree-20140225 NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.
- NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_assertion wasGeneratedBy ECO_0000203 NP458008.RAlWIoWsIqEC9dr_pDJRw8cMzsp3YrJEfP5rTWu4jIJlU130_provenance.